- CEO
- Chen Ding
- Full Time Employees
- 436
- Sector
- Non-energy minerals
- Industry
- Other metals/Minerals
- Address
- Huanyu Huijin Center Dongguan GD China 523073
- IPO Date
- Jul 23, 2007
- Business
- Infund Holding Co., Ltd. (002141.SZ) manufactures and sells fine and special enameled wires, copper-clad laminates, veterinary vaccines, and animal feed products primarily in China. The company offers polyurethane enameled copper round wires for small motors, transformers, ignition coils, and relays; polyester enameled copper round wires for general purpose motors, generators, and transformers; polyester-imide enameled copper round wires for heat-resistant motors and automotive components; self-bonding enameled copper round wires for speaker coils and voice coils; fine rectangular magnet wires; conventional FR-4/CEM-3 copper-clad plates; lead-free halogen-free FR-4 copper-clad plates; live and inactivated pig vaccines including blue ear, pseudorabies, and porcine circovirus types; and full-price pig feed. It operates in the electrical equipment, animal health, and materials sectors, serving electronic information, automotive, household appliance, defense, and livestock industries with customers including appliance makers and pig farms.
Founded in 1985 as a Sino-foreign joint venture and listed on the Shenzhen Stock Exchange SME board in 2007, Infund Holding Co., Ltd. is headquartered in Zhuhai, China, at Sanzao Technological Industry Park, with primary operations in China and sales extending to Southeast Asia and Europe. The company, formerly Guangdong Ronsen Super Micro-Wire Co., Ltd., changed its name to Infund Holding Co., Ltd. in January 2017 to reflect its diversified holding structure and business transformation. It holds national high-tech enterprise status, CNAS and GCP certifications, a Sichuan Enterprise Technology Center, a Postdoctoral Research Workstation, one Class I new veterinary drug certificate, and 28 authorized patents.
In recent developments, Infund Holding Co., Ltd. underwent a 2.42% stake acquisition by Jiangxi Xinyu Environmental Technology Co., Ltd. and Chen Xinxiong from Xianfeng Holding Group Co., signaling potential strategic realignments in ownership; reported earnings for the nine months ended September 30, 2025; and continues advancing its veterinary vaccine portfolio with services like African Swine Fever antibody screening and on-site audits amid ongoing business diversification from traditional enameled wires into animal nutrition and copper-clad plates.